Women Treated for Breast Cancer Experience Accelerated Biological Aging
Drug Topics
JULY 25, 2023
Radiation therapy was associated with the largest increase, compared to chemotherapy or endocrine therapies.
Tue.Jul 25, 2023
469 
In fast-growing KRAS field, this oncology veteran is chasing the toughest cancer targets
PharmaVoice
JULY 25, 2023
Loïc Vincent, chief scientific officer at Affini-T, explains the company’s T cell approach and latest moves toward the clinic.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Analysis Estimates 100 Million Non-COVID-19 Adult Vaccines Missed
Drug Topics
JULY 25, 2023
The report references adult vaccines, in terms of volume of use, for influenza, diphtheria and tetanus (Td), diphtheria, tetanus and pertussis (TDaP), hepatitis B, herpes zoster and pneumococcal.
Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 Diabetes
Pharmacy Times
JULY 25, 2023
Patients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Cigna hit with class action alleging it used an algorithm to reject claims
Fierce Healthcare
JULY 25, 2023
Two Cigna members have hit the insurer with a class action lawsuit, accusing the company of using an algorithm to improperly deny scores of patient claims. | Two Cigna members have hit the insurer with a class action lawsuit, accusing the company of using an algorithm to improperly deny scores of patient claims.
Experts Raise Questions, Potential Answers About Why COVID-19 Has Drastically Changed RSV Epidemiology
Pharmacy Times
JULY 25, 2023
The prolonged lack of viral exposure has likely increased the pool of children and adults vulnerable to respiratory syncytial virus, but questions remain.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Axatilimab Produces Significant Response in Patients with Fatal Post-Transplant Complication
Pharmacy Times
JULY 25, 2023
Co-developers Incyte and Syndax will submit a biologics license application to the FDA at the end of 2023 based on the results of a phase 2 trial among adult and pediatric patients with chronic graft-versus-host disease.
Novel antibody therapeutic demonstrates potential in GVHD
European Pharmaceutical Review
JULY 25, 2023
Axatilimab, an anti-CSF-1R antibody to treat chronic graft-versus-host disease (GVHD) has, in a pivotal Phase II trial, demonstrated overall response rates (ORR) of 74 percent, 67 percent and 50 percent, within the first six months of treatment. “[It] is the first investigational chronic GVHD treatment to target inflammation and fibrosis through the inhibition of disease associated macrophages,” stated Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals.
Dietary Supplement Labels May Not Indicate All Ingredients in Product
Pharmacy Times
JULY 25, 2023
Some of the analyzed dietary supplement products were found to contain FDA-prohibited substances.
Hospitals are seeing higher acuity patients, struggling to discharge to post-acute care settings, report finds
Fierce Healthcare
JULY 25, 2023
Hospitals are finding it harder to place patients into post-acute care settings, a new report finds. | The number of referrals to nursing homes and home health agencies per patient has increased over the last year, as has patient acuity. At the same time, referral rejection rates are also on the rise.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Maternal Hepatitis C During Pregnancy Increases Risk of Adverse Perinatal Outcomes
Pharmacy Times
JULY 25, 2023
The study authors said that further investigation is needed to explore specialized care for mothers and newborns who are affected by hepatitis C infections during pregnancy.
Opinion: Enough with the health care policy patchwork. It’s time for universal insurance
STAT
JULY 25, 2023
Everyone knows that the United States is the only high-income country without universal health insurance. According to the standard narrative, this is the inevitable result of U.S. exceptionalism — our different values, culture, and institutions. Not so. The impetus for universal coverage is as strong in the United States as in any other country.
Promoting Medication Safety Improves Health Outcomes
Pharmacy Times
JULY 25, 2023
Pharmacists should provide guidance on issues such as proper drug disposal and potential drug interactions.
Jardiance cleared in EU for CKD, challenging Forxiga
pharmaphorum
JULY 25, 2023
Jardiance cleared in EU for CKD, challenging Forxiga Phil.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Patients Who Self-Report as Recovered From SARS-CoV-2 Present No Cognitive Deficits Following Infection
Pharmacy Times
JULY 25, 2023
Further work is necessary to monitor and develop understanding of recovery for individuals with ongoing COVID-19 symptoms.
GLP-1 drugs are still in demand. Insurers are cutting back coverage in response, Found study shows
Fierce Healthcare
JULY 25, 2023
As demand surges for GLP-1 therapies, insurers are pulling back on coverage, according to new data from obesity care provider Found. | Sarah Jones Simmer, CEO of Found, said that the trends are likely the result of irresponsible prescribing for recreational reasons causing the pendulum to swing "all the way in the other direction," and it's leading to patients who have genuine medical need struggling to access these therapies.
Ragu rolls out Kettle Cooked sauces
Drug Store News
JULY 25, 2023
Ragu’s new Kettle Cooked sauce line is available in three varieties—marinara, roasted garlic and tomato basil.
Boehringer, Lilly secure EC approval for Jardiance to treat adults with CKD
Pharmaceutical Technology
JULY 25, 2023
Boehringer Ingelheim and Eli Lilly have secured approval from the EC for Jardiance to treat adults with chronic kidney disease (CKD).
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Altro Pharmaceuticals, LSPedia Team Up on DSCSA Compliance
Pharmaceutical Commerce
JULY 25, 2023
With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.
How to Find the Best Digital Marketing Agency for Your Business
Pharma Marketing Network
JULY 25, 2023
In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.
CVS Pharmacy debuts Universal Tools collection from one+other
Drug Store News
JULY 25, 2023
CVS Pharmacy's exclusive beauty and personal care brand, one+other puts accessibility at the forefront with inclusively designed self-care tools.
Biden admin proposes new mental health parity regulations
Fierce Healthcare
JULY 25, 2023
Amid a worsening mental health crisis, the Biden administration is proposing a slew of regulatory changes aimed at improving access to critical care. | Amid a worsening mental health crisis, the Biden administration is proposing a slew of regulatory changes aimed at improving access to critical care.
Watch DSN: DeCamara highlights Rite Aid’s investments in mental health initiatives
Drug Store News
JULY 25, 2023
Matthew DeCamara, executive director at Rite Aid Healthy Futures, discusses the retailer’s new program that addresses mental health concerns for youths.
AHIP, AMA, NAACOs team on playbook for value-based care
Fierce Healthcare
JULY 25, 2023
AHIP, the American Medical Association and the National Association of ACOs have teamed up to release a playbook that aims to arm stakeholders with best practices for value-based care. | Three major national organizations released a playbook to help payers and providers adapt to value-based care.
Albertsons reports strong Q1 fiscal 2023 results
Drug Store News
JULY 25, 2023
Albertsons’ net sales and other revenue was $24.1 billion during the quarter of fiscal 2023 compared to $23.3 billion during the prior year period.
Digitalising HPLC methods: the path to interoperability
European Pharmaceutical Review
JULY 25, 2023
What are the key challenges when it comes to sharing data? Companies frequently share data both internally and externally, as well as with partners and contract research organisations (CROs). That data is often captured and formatted in a way that is specific to the company of origin, or the manufacturer of the lab equipment used. Typically, these data are not interoperable.
CHS selling 3 Florida hospitals to Tampa General Hospital for $290M
Fierce Healthcare
JULY 25, 2023
Community Health Systems (CHS) announced that it has signed a deal to sell three Florida hospitals to Tampa General Hospital for roughly $290 million. | The divestiture of Bravera Health Brooksville, Bravera Health Seven Rivers and Bravera Health Spring Hill is slated to close later this year pending regulatory approval and other customary closing conditions.
From stealth to spotlight: Marketing strategies to begin
pharmaphorum
JULY 25, 2023
From stealth to spotlight: Marketing strategies to begin Mike.
STAT+: As Alzheimer’s drugs hit the market, the race for early detection blood tests heats up
STAT
JULY 25, 2023
With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush. Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.
Biogen wields axe again ahead of Leqembi rollout
pharmaphorum
JULY 25, 2023
Biogen wields axe again ahead of Leqembi rollout Phil.
Teladoc reports higher Q2 revenue, bullish on opportunities for virtual weight management, mental health
Fierce Healthcare
JULY 25, 2023
Editor's Note: The article has been updated with information from Teladoc's earnings call with investors late Tuesday afternoon. | Teladoc is doubling down on its strategy to focus on "whole person care" through its virtual care platform. The telehealth provider is seeing strong growth across its chronic care programs and virtual mental health and is eyeing opportunities in the booming weight management market.
Astellas builds in protein degraders with PeptiDream deal
pharmaphorum
JULY 25, 2023
Astellas builds in protein degraders with PeptiDream deal Phil.
Youth To The People names Omar Apollo as its 1st brand voice
Drug Store News
JULY 25, 2023
As brand voice, Omar Apollo will promote the relaunch of the Superfood Air-Whip Moisture Cream, as well as other category-expanding products.
Let's personalize your content